# Phase 39 Status

## Current state
ENGINEERING CORRECTION IN PROGRESS — NO NUMERICAL EVIDENCE ACCEPTED.

## Completed
- Frozen research plan, literature review, simulator, tests and workflow.
- Source diagnostic confirms exact 09:30 IV and representative execution quotes exist.
- E0391–E0396 corrected and logged.
- E0397 identified: execution price-map date-type mismatch caused false 0% execution coverage.

## Current data-gate finding
The same authoritative gate still has a genuine feature-eligibility failure: 838/1,174 post-warm-up sessions = 71.38%, below the frozen 95% threshold, despite 98.64% direct IV-input coverage. This is not being relaxed or retuned.

## Pending
1. Rerun after E0397 solely to replace the false execution-coverage measurement.
2. Close Phase 39 DATA-LIMITED if the feature-eligibility gate remains below 95%, regardless of execution coverage.
3. Then advance to the next preregistered distinct family.
